In April 2017, Lynn Goldin, Ph.D., retired after an outstanding career at the National Institutes of Health spanning 39 years. She is best known for her significant contributions to the development and evaluation of genetic epidemiology study methods and designs for complex diseases. Dr. Goldin first started working closely with DCEG investigators in the early 1980s to produce the first linkage analysis of familial melanoma in 1983. In 1998, she moved from the National Institute of Mental Health to the NCI as a senior investigator in the former Genetic Epidemiology Branch (GEB). In GEB, her work focused on characterizing the hereditary basis of lymphoid malignancies using statistical, genetic, population, and molecular approaches. She moved to the newly-formed Integrative Tumor Epidemiology Branch in 2017. Dr. Goldin worked closely with Neil Caporaso, M.D., and Mary Lou McMaster, M.D., on genetic studies of familial chronic lymphocytic leukemia, Hodgkin and non-Hodgkin lymphomas, and Waldenström macroglobulinemia.
In addition to her extensive scientific contributions, Dr. Goldin served as Deputy Chief of GEB (2011-2016) and was deeply involved in the mentoring of GEB fellows and tenure track investigators. She also supported the careers of junior investigators across the Division as DCEG representative to the NIH Women Scientists Advisory Group and as a member of the DCEG Promotion and Tenure Review Panel.